Obinutuzumab
Update Venetoclax in CLL
(Update) Acalabrutinib in CLL and MCL
Zanubrutinib
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL
JNCCN: How To Manage Cancer Care During COVID-19 Pandemic
CLL Society
UpToDate